MACULAR TELANGIECTASIA

Clinical trials for MACULAR TELANGIECTASIA explained in plain language.

Never miss a new study

Get alerted when new MACULAR TELANGIECTASIA trials appear

Sign up with your email to follow new studies for MACULAR TELANGIECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Eye injection trial for rare vision disease halted early

Disease control Terminated

This study tested whether aflibercept eye injections could reduce swelling in the retina caused by a rare eye disease called Macular Telangiectasia Type 1. It was a Phase 3 trial that planned to compare the drug against a placebo injection in 16 participants over 6 months. The tr…

Matched conditions: MACULAR TELANGIECTASIA

Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

MACULAR TELANGIECTASIA

Get alerted when new MACULAR TELANGIECTASIA trials appear

Eye injection trial for rare vision disease halted early